Associations - FGFR mutation

FGFR mutation FGFR mutation	Urothelial Cancer Urothelial Cancer	erdafitinib Sensitive: C2 – Inclusion Criteria
FGFR mutation FGFR mutation	Urothelial Cancer Urothelial Cancer	erdafitinib + JNJ-63723283 Sensitive: C3 – Early Trials
FGFR mutation FGFR mutation	Urothelial Cancer Urothelial Cancer	FGFR inhibitor Sensitive: C3 – Early Trials
FGFR mutation FGFR mutation	Solid Tumor Solid Tumor	ICP-192 Sensitive: C3 – Early Trials
FGFR mutation FGFR mutation	Breast Cancer Breast Cancer	E7090 Sensitive: D – Preclinical

Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.